Saillant Therapeutics
PrivateMomentum
Top 50%
of companies Caplight tracks
Company Overview
Saillant Therapeutics is a biotechnology company that develops small molecule-based therapies for the treatment of heart failure, Alzheimer's disease, and viral infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Saillant Therapeutics Comparables
Compare Saillant Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GliaPharm SA | 83% | |
| Cornovus Pharmaceuticals Inc. | 74% | |
| HAYA Therapeutics | 70% | |
Saillant Therapeutics Funding Rounds
Historical fundraising activity
Saillant Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Stichting RedMedTech Discovery Fund | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 17, 2026
Monthly visitors increased 45% MoM.
- Jan 20, 2026
Monthly visitors increased 153% MoM.
Saillant Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Saillant Therapeutics's valuation, stock price, and market status.